An Unusual Cause of Fever and Headache in a School-Aged Male

Abstract

Get full access to this article

View all access options for this article.

References

Perez

Bush

LM.

Balamuthia mandrillaris amebic encephalitis. Curr Infect Dis Rep. 2007;9:323-328.

Cope

Puttagunta

Gomez

et al . Clinical features of Balamuthia mandrillaris disease in the United States, 1974-2014. Open Forum Infect Dis. 2015;2(suppl 1):1343. doi:10.1093/ofid/ofv131.134.

Baig

Khan

NA.

A proposed cascade of vascular events leading to granulomatous amoebic encephalitis. Microb Pathog. 2015;88:48-51.

Schuster

Yagi

Gavali

et al . Under the radar: Balamuthia amebic encephalitis. Clin Infect Dis. 2009;48:879-887.

Qvarnstrom

Visvesvara

Sriram

da Silva

AJ.

Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol. 2006;44:3589-3595.

Parija

Dinoop

Venugopal

Management of granulomatous amebic encephalitis: laboratory diagnosis and treatment. Trop Parasitol. 2015;5:23-28.

Centers for Disease Control and Prevention. Investigational drug available directly from CDC for the treatment of infections with free-living amebae. MMWR Morb Mortal Wkly Rep. 2013;62:666.

Schuster

Honarmand

Visvesvara

Glaser

CA.

Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Clin Infect Dis. 2006;42:1260-1265.

Schuster

Guglielmo

Visvesvara

GS.

In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006;53:121-126.

10.

Ahmad

Heaselgrave

Andrew

Kilvington

The in vitro efficacy of antimicrobial agents against the pathogenic free-living amoeba Balamuthia mandrillaris. J Eukaryot Microbiol. 2013;60:539-543.